Elevating Wellness through Evidence-Based
Nutraceuticals
In healthcare, the concept of "evidence-based medicine" is well-established. At Zum Heilen, we extend this principle to nutrition, where we champion evidence-based food as a transformative approach. This approach empowers individuals to make judicious choices regarding fortified foods that hold the potential to enhance their health and overall well-being.
Central to our approach is the remarkable spice "Cardamom," replete with bioactive constituents well-known for their diverse health benefits. We are diligently engaged in pioneering bioavailability testing methodologies for novel food products fortified with cardamom bioactives. This rigorous endeavor ensures that these consumables are effective and secure contributions to one's dietary regimen.
At Zum Heilen, our vision is to extend the reach of these functional foods to all corners of the globe, transcending boundaries of nationality and tradition.
We aim to improve health through diet.
​
​
Breast cancer, particularly its variant Triple Receptor Negative Breast Cancer, has been our primary area of focus. This variant is witnessing a global increase in incidence, affecting a younger demographic and often resulting in poorer prognoses and limited responses to chemotherapy. Despite significant ongoing efforts to develop new chemotherapy agents for this disease, it is crucial to underscore the associated financial costs and side effects.
​
The proposition to combat this disease using food as an additional powerhouse does not always garner the attention it deserves within the healthcare field. Our ongoing work involves the development of an artificial intelligence and machine learning model. This model leverages data from the cell culture of tumor cells and their response to standard chemotherapy, highlighting the synergistic benefits of incorporating cardamom bioactives. This innovative approach empowers patients to opt for fortified foods that can enhance their recovery without introducing additional side effects.
​
Patients have a range of dietary product choices, from indulging in a simple chocolate topping on a dessert after a regular meal to incorporating specially fortified salt and pepper as seasonings in their breakfast omelets or early evening soups.
​
​
Triple Negative Breast Cancer (TNBC)
​
Extensive research has investigated the connection between dental diseases, specifically Periodontitis, and Myocardial Infarction (heart attacks) in various countries. An increasing body of evidence highlights the implications of the red complex bacteria in such studies. We are currently engaged in a study to explore this link further by identifying anaerobic bacteria present in both the oral cavity and atheromatous plaques responsible for causing coronary vascular disease. Our research relies on the utilization of our proprietary molecular diagnostic kits for this purpose.
​
​
Early Dental Screening and Care for Preventive Cardiology
​
1-8 Cineol, standardized in our proprietary 'RECOVEREEZ' formulations, has undergone clinical testing and validation. Additionally, 1-8 Cineol is a compound that has been extensively studied globally by various scientific teams for its potential benefits in acute and chronic respiratory diseases, reducing dependency on steroids in steroid-dependent users, addressing inflammatory bowel disease, managing liver diseases, including liver failure, and addressing neurologic diseases such as Alzheimer's disease.
Research has also explored its potential in the context of cancer and dental diseases.
At ZH Corp, our uniqueness lies in offering molecular diagnostic test kits based on the RTPCR platform, originating from our research projects. We provide these test kits to like-minded researchers and aim to expand their use in comprehensive care packages. These packages include monitoring the downregulation or control of genetic biomarkers through saliva tests, which are sent to our partner labs.
​
​
​
​
​
​
​
​
​
​
​
​
Researched and Proven: 1-8 Cineol - The Cardamom Bioactive